July 20th, 2017 Deton Corp. has been awarded a $225,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR) contract. The award will fund a clinical study to investigate the advantages of using the Deton Cough Collector for pediatric Cystic Fibrosis patients with lower respiratory infections ...
Read More
Jul 20, 2017 Julia Karow – New York Startup SeqOnce Biosciences is aiming to increase the speed and user-friendliness of library preparation for next generation sequencing. The company, a 2014 spinout from the University of Southern California, is getting ready to roll out its first products later this year, DNA library prep kits called Rapid DNA-seq that use a proprietary sample prep chemistry the firm licenses from USC. In addition, SeqOnce is developing a metal nanoparticle technology for a variety of applications, including biomolecule purification and targeted sequencing. According to CEO and co-founder Chris Angermayer, the privately held company, which is located in the Pasadena Bio collaborative incubator, is seeking to raise $3 million in a Series A funding round this ...
Read More
Media Contact: Bill Bogaard, Chairman, (626) 864-9819, <w_j_b@msn.com> PASADENA, Calif.—Pasadena Bio Collaborative Incubator (PBC), high tech incubator for early stage start-ups and a regional workforce development magnet for scientists seeking wet lab R&D competency, announced the resignation from the Board of Directors of William Opel, MBA and PhD.  The resignation is effective as of June 30. “Bill has been a board member since PBC first began operations in 2004 and his many contributions have been a significant factor in our growth”, said PBC Chairman and former Pasadena mayor Bill Bogaard.  “We are truly grateful for his years of dedicated service and his wise counsel to the board and to management.” Dr. Opel was the President and CEO of Huntington Medical Research ...
Read More
LOS ANGELES – August 4, 2016 – Deton Corp., a medical device company developing innovative products for the diagnosis of lower respiratory infections, has secured $600,000 in an oversubscribed seed financing round. The round was led by a venture fund based in Shanghai and included angel investor participation. “The seed financing comes at a pivotal time for the company, as we accelerate our ongoing efforts in product and market development,” said Patrick Sislian, Ph.D., CEO of Deton Corp. “This financing gets us closer to our goal of becoming the world-leaders in non-invasive sample collection from the lower respiratory tract.” ​ Deton’s product, the Cough Collector, addresses long standing challenges in the diagnosis of lower respiratory infections. “The Cough Collector is ...
Read More